Skip to content
Non-Current Liabilities

Total Liabilities

Pfizer Total Liabilities increased by 4.9% to $3.41B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 97.1%, from $117.39B to $3.41B. Over 5 years (FY 2020 to FY 2025), Total Liabilities shows a downward trend with a -48.6% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.

Analysis

StatementBalance Sheet Statement
SectionNon-Current Liabilities
CategoryLeverage
SignalLower is better
VolatilityStable
First reportedQ4 2014
Last reportedQ1 2026May 5, 2026

How to read this metric

A rising total liability balance relative to equity indicates increasing leverage, which may heighten financial risk, especially if not matched by growth in assets.

Detailed definition

This is the comprehensive sum of all current and non-current liabilities owed by the company to external parties. It rep...

Peer comparison

A fundamental metric for assessing the overall solvency and capital structure of a company compared to its industry peers.

Metric ID: total_liabilities

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$99.61B$103.22B$104.01B$101.16B$107.82B$102.46B$101.29B$94.38B$120.88B$117.82B$137.21B$128.54B$128.22B$126.92B$124.9B$117.39B$117.08B$115.64B$3.25B$3.41B
QoQ Change+3.6%+0.8%-2.7%+6.6%-5.0%-1.1%-6.8%+28.1%-2.5%+16.5%-6.3%-0.2%-1.0%-1.6%-6.0%-0.3%-1.2%-97.2%+4.9%
YoY Change+8.2%-0.7%-2.6%-6.7%+12.1%+15.0%+35.5%+36.2%+6.1%+7.7%-9.0%-8.7%-8.7%-8.9%-97.4%-97.1%
Range$3.25B$137.21B
CAGR-50.9%
Avg YoY Growth-7.4%
Median YoY Growth-1.7%

Frequently Asked Questions

What is Pfizer's total liabilities?
Pfizer (PFE) reported total liabilities of $3.41B in Q1 2026.
How has Pfizer's total liabilities changed year-over-year?
Pfizer's total liabilities decreased by 97.1% year-over-year, from $117.39B to $3.41B.
What is the long-term trend for Pfizer's total liabilities?
Over 5 years (2020 to 2025), Pfizer's total liabilities has grown at a -48.6% compound annual growth rate (CAGR), from $90.76B to $3.25B.
What does total liabilities mean?
The total amount of all debts and obligations owed by the company.